BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 28127819)

  • 21. Incidence and evaluation of an AGUS Papanicolaou smear in primary care.
    Valdini A; Vaccaro C; Pechinsky G; Abernathy V
    J Am Board Fam Pract; 2001; 14(3):172-7. PubMed ID: 11355048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytological diagnosis of cervico-uterine cancer in pregnant and puerperal women].
    Chuaqui R; Quintana ME; Pérez A; Verni J; Duarte I
    Rev Chil Obstet Ginecol; 1994; 59(3):207-13. PubMed ID: 7659814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined cytology and colposcopy to screen for cervical cancer in pregnancy.
    Guerra B; De Simone P; Gabrielli S; Falco P; Montanari G; Bovicelli L
    J Reprod Med; 1998 Aug; 43(8):647-53. PubMed ID: 9749413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.
    Kim MK; Lee IH; Lee KH; Lee YK; So KA; Hong SR; Hwang CS; Kee MK; Rhee JE; Kang C; Hur SY; Park JS; Kim TJ
    J Gynecol Oncol; 2016 Mar; 27(2):e14. PubMed ID: 26768780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The adequate Papanicolaou smear revisited.
    Greening SE
    Diagn Cytopathol; 1985; 1(1):55-8. PubMed ID: 3836072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults.
    Agénor M; White Hughto JM; Peitzmeier SM; Potter J; Deutsch MB; Pardee DJ; Reisner SL
    J Gen Intern Med; 2018 Jul; 33(7):1015-1017. PubMed ID: 29654599
    [No Abstract]   [Full Text] [Related]  

  • 27. Malignancy during pregnancy in Japan: an exceptional opportunity for early diagnosis.
    Sekine M; Kobayashi Y; Tabata T; Sudo T; Nishimura R; Matsuo K; Grubbs BH; Enomoto T; Ikeda T
    BMC Pregnancy Childbirth; 2018 Feb; 18(1):50. PubMed ID: 29422016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Papanicolaou smear-test screening in pregnancy.
    Abraham S; Llewellyn-Jones D
    Med J Aust; 1989 Jul; 151(2):116. PubMed ID: 2739606
    [No Abstract]   [Full Text] [Related]  

  • 29. A methodological framework to distinguish spectrum effects from spectrum biases and to assess diagnostic and screening test accuracy for patient populations: application to the Papanicolaou cervical cancer smear test.
    Elie C; Coste J;
    BMC Med Res Methodol; 2008 Feb; 8():7. PubMed ID: 18291032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of beliefs about cancer detection and taking Papanicolaou tests.
    Kegeles SS; Kirscht JP; Haefner DP; Rosenstock IM
    Public Health Rep (1896); 1965 Sep; 80(9):815-23. PubMed ID: 4953245
    [No Abstract]   [Full Text] [Related]  

  • 31. Carcinoma of cervix with recent normal Papanicolaou tests.
    Prendiville W; Guillebeaud J; Bamford P; Beilby J; Steele SJ
    Lancet; 1980 Oct; 2(8199):853-4. PubMed ID: 6107514
    [No Abstract]   [Full Text] [Related]  

  • 32. Using reminder systems to improve Papanicolaou test follow-up. An example of continuous quality improvement.
    Eilers GM; Swanson TK
    Arch Fam Med; 1993 Nov; 2(11):1136-40. PubMed ID: 8124488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The routine use of the Papanicolaou smear in pregnant women.
    HILL HM; PRYSTOWSKY H
    South Med J; 1961 Mar; 54():291-4. PubMed ID: 13714279
    [No Abstract]   [Full Text] [Related]  

  • 34. Papanicolaou test in the early diagnosis of uterine cancer.
    HUFFORD CE; BURNS EL
    Ohio State Med J; 1948 Sep; 44(9):900-3. PubMed ID: 18879503
    [No Abstract]   [Full Text] [Related]  

  • 35. The cancer program in New Jersey, part II A. Papanicolaou smears in the diagnosis of malignancy.
    BERNHARD WG; RUSH M
    J Med Soc N J; 1951 Jun; 48(6):255-8. PubMed ID: 14850913
    [No Abstract]   [Full Text] [Related]  

  • 36. The Papanicolaou test in the cancer control program.
    BROWN WE; BRADBURY JT; KRAUSHAAR OF
    J Kans Med Soc; 1949 May; 50(5):217-21. PubMed ID: 18120901
    [No Abstract]   [Full Text] [Related]  

  • 37. Limitations of cytological cervical cancer screening (Papanicolaou test) regarding technical and cultural aspect in rural India.
    Nikumbh DB; Nikumbh RD; Kanthikar SN
    South Asian J Cancer; 2016; 5(2):79. PubMed ID: 27275455
    [No Abstract]   [Full Text] [Related]  

  • 38. A deadly cold.
    Kolade VO
    Proc (Bayl Univ Med Cent); 2022; 35(3):398. PubMed ID: 35518829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Papanicolaou method.
    GIFFEN HK
    Am J Clin Pathol; 1948 Apr; 18(4):330. PubMed ID: 18907108
    [No Abstract]   [Full Text] [Related]  

  • 40. [Contribution to clinical cancer diagnosis; the cell staining according to Papanicolaou].
    SCHAFFNER A
    Helv Chir Acta; 1949 Oct; 16(4-5):233-44. PubMed ID: 15392024
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.